Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis
Johny Nicolas(Cardiovascular Institute of the South), Roxana Mehran(Mount Sinai Hospital), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Carlo Andrea Pivato(Cardiovascular Institute of the South), Birgit Vogel(Cardiovascular Institute of the South), Gennaro Giustino(Cardiovascular Institute of the South), George Dangas(Mount Sinai Hospital), Ko Yamamoto(Kyoto University), Anton Camaj(Columbia University Irving Medical Center), Alessandro Spirito(University of Bern), Usman Baber(Icahn School of Medicine at Mount Sinai), Mauro Chiarito(Humanitas University), Frans Beerkens(Icahn School of Medicine at Mount Sinai), Davide Cao(Cardiovascular Institute of the South), Takeshi Kimura(Municipal Hirakata City Hospital), Byeong‐Keuk Kim(Yonsei University)
Cited by 21
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k